Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
RYBELSUS : A1C reduction demonstrated at 52 weeks Statistically significant A1C reduction vs Jardiance 2* Statistically significant A1C control vs Jardiance 2* PIONEER 2 study design 1,2 In an open-label trial with a primary endpoint of mean change in A1C from baseline to 26 weeks, 822 adult patients with type 2 diabetes on metformin were randomized to RYBELSUS 14 mg (n=411) or Jardiance 25 mg (n=410), both once daily
Making GLP-1 Treatment Accessible The reality is stark: brand-name Ozempic at $969 monthly is financially impossible for most people without substantial insurance assistance
2002 Dec;56(6):295-301
Biochemical determination of islet lysosomal enzyme activities following crinophagy-stimulating treatment with diazoxide in mice
